BLUE - Bluebird bio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BLUE is currently covered by 7 analysts with an average price target of $-53.22. This is a potential upside of $-57.17 (-1447.34%) from yesterday's end of day stock price of $3.95.

Bluebird bio's activity chart (see below) currently has 7 price targets and 49 ratings on display. The stock rating distribution of BLUE is 47.06% BUY, 11.76% SELL and 41.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.07% with an average time for these price targets to be met of 284.29 days.

Highest price target for BLUE is $8, Lowest price target is $3, average price target is $6.43.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 31-Mar-2025.

Currently out of the existing stock ratings of BLUE, 8 are a BUY (47.06%), 2 are a SELL (11.76%), 7 are a HOLD (41.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$3.84 (92.31%)

$40

1 months 2 days ago
(31-Mar-2025)

1/4 (25%)

$3.12 (63.93%)

195

Hold

$5

$0.84 (20.19%)

$2

2 months 9 days ago
(24-Feb-2025)

1/2 (50%)

$0.92 (22.55%)

36

Hold

$8

$3.84 (92.31%)

$4

3 months 26 days ago
(07-Jan-2025)

5/5 (100%)

$-1.02 (-11.31%)

134

Buy

$6

4 months 17 days ago
(16-Dec-2024)

1/1 (100%)

$-8.11 (-57.48%)

98

Hold

$3

$-1.16 (-27.88%)

$3

5 months 18 days ago
(15-Nov-2024)

0/3 (0%)

$-3.42 (-53.27%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BLUE (Bluebird bio) average time for price targets to be met?

On average it took 284.29 days on average for the stock forecasts to be realized with a an average price target met ratio 60.07

Which analyst has the current highest performing score on BLUE (Bluebird bio) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on BLUE (Bluebird bio)?

Salveen Richter works at GOLDMAN SACHS and has 8 price targets and 5 ratings on BLUE

Which analyst is the currently most bullish on BLUE (Bluebird bio)?

Edward Nash with highest potential upside - $106.4

Which analyst is the currently most reserved on BLUE (Bluebird bio)?

Matthew Harrison with lowest potential downside - -$3.29

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?